alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
----

**Exhibit      (10)-w**

**BAUSCH      & LOMB INCORPORATED**

**SUPPLEMENTAL      RETIREMENT INCOME PLAN III**

**Amendment      No. 2 to the 2001 Restatement**

| §   | All                Plan benefits that have accrued as of December 31, 2005 shall be                frozen at                their then-accrued levels and thereafter additional benefit accruals,                including contribution credits based on compensation paid after December                31, 2005, shall cease. Notwithstanding the foregoing, interest credits                shall continue to be credited on the frozen benefit accruals in such                amount and determined in accordance with such procedures as are used                to                credit interest to Steady Growth Accounts under the Funded                Plan. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| §   | No                service or compensation earned by a Participant after December 31,                2005                shall be taken into account in determining a Participant’s accrued benefit                under this Plan. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| §   | All                vested accrued benefits as of December 31, 2005 shall remain vested                and                any unvested benefits shall vest in accordance with the Plan’s                terms. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| §   | No                Employee not already a Participant shall be eligible to become a                Participant on or after December 31,                2005. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

**BAUSCH      & LOMB INCORPORATED**
97-31.

#### State v. Young.

Lucas App. No. L-95-288. On motion for leave to file delayed appeal. Motion granted.

Douglas and F.E. Sweeney, JJ., dissent.
# Office of Neural Exposome and Toxicology Research

The National Institute of Neurological Disorders and Stroke (NINDS) supports basic, translational, and clinical research on the brain and nervous system and uses that knowledge to reduce the burden of neurological disease for all people. Within the Division of Translational Research (DTR) at NINDS, the Office of Neural Exposome and Toxicology (ONETOX) supports research and provides resources to advance knowledge of internal and external exposures that affect brain and nervous system health (Neural Exposome), leads research related to chemical threats, and provides resources that promote chemical safety. 

ONETOX has three branches:

bacteria

biohazard

flask

> Image
Dr. David Jett is the Director of the Office of Neural Exposome and Toxicology Research (ONETOX) at NINDS. He also serves as Program Director and Scientific Team Leader within the Division of Translational Research (DTR).  Dr. Jett has been at NINDS since 2001 and has led several programs including the development and launching the NIH CounterACT program after 9/11.  Prior to NINDS, he was faculty at Johns Hopkins University where his lab focused on the impact of chemical agents on nervous system function, including the molecular and cellular mechanisms of cognitive and neural development.

## Resources and Tools

### Contacts

David A. Jett, Ph.D. | Director, ONETOXjettd@ninds.nih.gov

Neel Dhruv, Ph.D. | Health Program Specialistneel.dhruv@nih.gov

Amir Tamiz, Ph.D. | Director, Division of Translational Researchamir.tamiz@nih.gov

### Funding Opportunities 

Neural Exposome Funding Opportunities

Neural Exposome Notices and Other Funding Announcements

Chemical Threats Funding Opportunities

Chemical Threats Notices and Other Funding Announcements

Chemical Safety Funding Opportunities

Chemical Safety Notices

### News & Events

Tamiz AP, Koroshetz WJ, Dhruv NT, Jett DA. 2022. A focus on the neural exposome. Neuron. PMID: 35349785.
> 
Virtual Mini Workshop: The Right Tools and Resources for Neural Exposome ResearchApril 19, 2024 | 1PM ET

Virtual Mini Workshop: Team Science to Advance Neural Exposome ResearchFebruary 29, 2024 | 1PM EST

OPEN Stage Webinar: The Neural Exposome - How NINDS is Supporting Exposomic ResearchOctober 23, 2023 | 1PM EDT

Workshop: Status Epilepticus after Benzodiazepines: Seizures and Improving Long Term OutcomesFebruary 28 - March 1, 2023

Neuroscience 2022: The Neural Exposome and Why it's Important to You! | November 15, 2022; 6:30 pm PST
EXHIBIT 31.1



CERTIFICATIONS



I, Patrick M. Flynn, certify that:



1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended October 31, 2004 of Blue Ridge Real Estate Company and Big Boulder Corporation (together , the Registrants);



2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b) [paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986];



(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially



affect, the registrants internal control over financial reporting; and



5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants boards of directors (or persons performing the equivalent functions):



(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and



(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.



Date: February 11, 2005



/s/ Patrick M. Flynn

Patrick M. Flynn

Chief Executive Officer

and President
<TABLE> <S> <C>

<PAGE>
<ARTICLE> UT
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
CONSTELLATION ENERGY'S DECEMBER 31, 1999 CONSOLIDATED INCOME STATEMENT, BALANCE
SHEET AND STATEMENT OF CASH FLOWS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH STATEMENTS.
</LEGEND>
<CIK> 0001004440
<NAME> CONSTELLATION ENERGY GROUP INC.
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<BOOK-VALUE>                                  PER-BOOK
<TOTAL-NET-UTILITY-PLANT>                        5,523
<OTHER-PROPERTY-AND-INVEST>                      1,981
<TOTAL-CURRENT-ASSETS>                           1,491
<TOTAL-DEFERRED-CHARGES>                           689
<OTHER-ASSETS>                                       0
<TOTAL-ASSETS>                                   9,684
<COMMON>                                         1,494
<CAPITAL-SURPLUS-PAID-IN>                            0
<RETAINED-EARNINGS>                              1,499
<TOTAL-COMMON-STOCKHOLDERS-EQ>                   2,993
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        190
<LONG-TERM-DEBT-NET>                             2,575
<SHORT-TERM-NOTES>                                   0
<LONG-TERM-NOTES-PAYABLE>                            0
<COMMERCIAL-PAPER-OBLIGATIONS>                     372
<LONG-TERM-DEBT-CURRENT-PORT>                      808
<PREFERRED-STOCK-CURRENT>                            0
<CAPITAL-LEASE-OBLIGATIONS>                          0
<LEASES-CURRENT>                                     0
<OTHER-ITEMS-CAPITAL-AND-LIAB>                   2,746
<TOT-CAPITALIZATION-AND-LIAB>                    9,684
<GROSS-OPERATING-REVENUE>                        3,786
<INCOME-TAX-EXPENSE>                               186
<OTHER-OPERATING-EXPENSES>                       3,026
<TOTAL-OPERATING-EXPENSES>                       3,212
<OPERATING-INCOME-LOSS>                            574
<OTHER-INCOME-NET>                                   7
<INCOME-BEFORE-INTEREST-EXPEN>                     581
<TOTAL-INTEREST-EXPENSE>                           255
<NET-INCOME>                                       260
<PREFERRED-STOCK-DIVIDENDS>                          0
<EARNINGS-AVAILABLE-FOR-COMM>                      260
<COMMON-STOCK-DIVIDENDS>                           251
<TOTAL-INTEREST-ON-BONDS>                          230
<CASH-FLOW-OPERATIONS>                             679
<EPS-BASIC>                                       1.74
<EPS-DILUTED>                                     1.74


</TABLE>
# Fourth Court of Appeals

**San Antonio, Texas**

JUDG MENT

No. 04

- 15

- 00124

- CR

Hector RAMIREZ

, Appellant

v.

The STATE of Texas,

Appellee

From the 227th Judicial District Court, Bexar County, Texas

Trial Court No. 2013CR2894

Honorable Kevin M. O ’ Connell, Judge Presiding

BEFORE JUSTICE ANGELINI

, JUSTICE BARNARD , AND JUSTICE MARTINEZ

In accordance with this court’s opinion of this date, appellant’s motion to dismiss is

GRANTED, and this appeal is DISMISSED.

SIGNED December 9, 2015.

_________________________________ Karen Angelini, Justice

‘
# U ni te d S ta te s Co ur t of A pp ea ls For the Eig hth Circu it

__ __ __ __ __ __ __ __ __ __ __ __ __ _ No. 1 2- 35 53

__ __ __ __ __ __ __ __ __ __ __ __ __ _ Fred eri ckL. Pit ch fo rd
ll ll ll ll ll ll ll ll ll ll l Pla in ti

ff - App el la nt

v. Equ al Em pl oym en t Op po rtu ni ty Comm is si on ; Sh irl ey McGee , em

pl oyee of EEOC, in pe rs on al cap aci ty; Marg ie My ers , em pl oyee of EEOC, in p ers on al cap aci ty; W an daMi lt on , em

pl oyee of EEOC, in p ers on al cap aci ty
ll ll ll ll ll ll ll ll ll ll l Defe nd

an ts - App el le es

__ __ __ __ __ __ App eal fro m

Uni te d S ta te s Di st ric t Co urt fo r th e Eas te rnDis tri ctof Ark an sa s - J on es bo ro

__ __ __ __ __ __ Subm it te d: May 3, 20 13 Fi le d: May 8, 20 13 [Unpubl is he d]

__ __ __ __ __ __ Befo re MUR PHY, SMITH, an d C OLLOTO N, Circ ui t Jud ge s.

__ __ __ __ __ __ PER CURI AM.Fred eri ck Pi tc hf or d ap pe al s th e di st ric t co urt’s di sm is sa l of hi s 42 U.S.C. 1 § 1 98 5 c om

pl ai nt . After c aref

ul rev ie w, we con cl ud e th atth e d is m is sa l was pro pe r fo r th e reas on s st at ed by th e di st ric t co urt. See Gom et z v. Cu lwel l, 85 0 F.2 d 46 1, 46 4 (8 th Ci r. 19 88 ) (to st at e § 19 85 (2 ) cl ai m , pl ai nt iff m us t al le g e w i t h s u f

fic ie nt pa rti cu la rit y th at parti es reac he d so m e ag reem en t and co ns pi red to ge th er to dep riv e pl ai nt iff of fed eral rig ht ); Harri so n v. Sp rin gd al e W at er & Sewer Co m m ’n, 78 0 F.2 d 14 22 , 14 30 (8 th Ci r. 19 86 ) (equa l pr ot ect io n pr ov is io n o f § 19 85 (3 ) requi res al le ga ti on of c la ss -b as edan im us ). Acco rd in gl y , we affi rm . See 8 th Cir . R. 47 B.

__ __ __ __ __ __ __ __ __ __ __ __ __ __ __

The Hon or ab le Bri an S. Mi ll er, Ch ie f Ju dg e, Uni te d St at es Dis tri ct Co urt fo r 1 th e Eas te rnDis tri ctof Ark an sa s. -2

-
----

----

----

----

----

|   | ATLAS MINING COMPANY                    |
|--------|-----------------------------------------|
|   |                                    |
|   | By: /s/ Andre Zeitoun                   |
|   | Its:  Chief Executive Officer |
|   |                                    |
|   |                                    |
|   | AAMCOR LLC                              |
|   | By:                                     |
|   | Its                                     |
|   |                                    |
|   |                                    |
|   |                                    |
|   |                                    |
|   |                                    |

----
<PAGE>

                                                                    Exhibit 32.0

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies, in his capacity as an officer of Barr
Laboratories, Inc. (the "Company"), for the purposes of 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
the best of his knowledge:

(1) The Annual Report of the Company on Form 10-K/A for the period ended June
30, 2003 fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Dated: August 29, 2003

/s/Bruce L. Downey
------------------
Bruce L. Downey
Chief Executive Officer

/s/William T. McKee
-------------------
William T. McKee
Chief Financial Officer

A signed original of this written statement required by Section 906 has been
provided to Barr Laboratories, Inc. and will be retained by Barr Laboratories,
Inc. and furnished to the Securities and Exchange Commission or its staff upon
request.
#     Avindra Nath, M.D.  

natha@mail.nih.gov

+1 301 496 1561

----

View Dr. Nath's full profile on the NINDS Division of Intramural Research site.
RECEIVED

JUL 152015. tCG vjVl 6MX, di QjxNVCk^ ^ • °*<^

( 11/ \ S w

•ofT\cv<G£0 's-|..JiLt—H

SECOND _

DEBRA SP&AA, CLERK

MCA Uo--^ ^jMC^xaCV OtXsoiC>oX!}^CJr

V.i

I&Qjw J^xXS. -7) ft \ACJ

(Z\i\%suk)

\ ." r

U ., )j\-\, ^

U. L.v

CdxU^

A - '-^ <^±kJUU <&-K L^v^XfijCkil -v UNA

wo ' ^

^ "*? ••&••*>•

ilrAHIp

V

^oa-ib^oi^a-c:^

'T a\ VXJZxxJ^S^J^

f <i i

i\

(KcSiLuJ<sS\^KysL.& wQ "V<S

A

(l 0

A'

CL'\\(& -J^j6^v£ JKVB CiUk<msu£-.0 ^^ 'J^^^-Qla-G^ OO^Ou.

£< oi vJ CLKV J^-X:au^A: .../HM.Djvd.A (.9f,,A'u^ vQjs..u~Vv. CUICL^uje

C^

•jWJUi^Ji^

.a.

Pao^-v «^a
A

S-^r

-si ' ' t\ :

JjNfwV

x n*^hajv

•JCU.iv

^ c^^^oA^ c^ojjj^ ^c^3^v(^ Jn\xu^^iA>

fv t

V)

He.

JTCW^ sWcsjuJU*

\i (C V V, SoJL

Cx>w ^._y"v--

\W^a<s^
\* f v

D

1 ....

"""(IS:

m^m? CD (Tw>

Vc^i
v. i.JL.C lii.^vQj* vJ u;> -:-ovS-c-i>"

ft.(Quid iSk Qjp&iokjs JOo,a Or3" \5" OO vri a - Cv{

/A jvioiJ c<s^ C^^ fx\oa O 'a>\ 5 - s - vab 5-5-1

r- -' ^ O

\ s i 'N Px v " * \ F* r\ A. ) * 'I

^ H

V^-o^V ^

c
......r t-

*

O i

SlS'SXXUS* xc&

._v O CLO LJJvi\ii.-\V. /""'AC^UVaIj^ 0.C^u^^i" .3-V\iiiv^\/-.,v./^

CC^\?'viL.C3Li-QL^\j3 Qj,J>d

^jx-Z-fcxliS^ dciiku,sv^-D o"^Gl$ tO oWfeuii oJvcfi ^^W^Quu^JXcD *..

Cii lJ. a

1 V^USLGljJtt*} ^UQ/vd "Vj&> JUjJiiL C\ ^Up

cAvAayA'

V

, /;

G

VTM/£C t*C 2l& \l£f

u v

!v v;

(^xv.^ -tJyu&t AiL ^fi^oi^L ^X^ \j^(^\ii*jr 0

\axX^-

^
UJKW^6g\\_X Ca&wc

iiUJ^ 1 O

U3

t *Hi vo/

E^J5 Qsy^Soj^ ^Co Se

^>^sj<sLsS_-

Al Wv| ^<k>lA A- ^(Aa^ u^pev OoAo^ QiAais^

id (X AujJu drcuS. Q_(Sl5\S£.cJi AxQlx„ cs/\ Aut_

QAj-c^(>ii- ij^au^'TCUL^ uio-o -C>.jixv/"^4) oAv Am_

AWAA Oojutffte*-- v Weston

Ocs&sjc n?

M^A)<ai& AvAlWt^

WuniAoVX T. CVftdc

r~\ ^ -

k<Dv30^<i Acit Wo o£

^QuOjL^bti^S
r\

: J(iAViA-d La£A\N^xa , ^\Ajj&J.) n V.X--.JW- QS^j VjL/vSi.

i-V.

Vw^

A

iv-4.

Ue^to- oau

a-^ou3 UJisJviJiU f/^l4jofaj3

' ' [ 'AuvHb- ©an

r\

W^o \iccL\d v^^\Ju^\fli" \JAJ^xLtV CJd^3A^

°Uo W4

,»^j

^£^S^K(^k^(^^}J^J^ ^+ OTi^xJvJ}

r

^W<ArH*b 3
AA^fa\5 (biAAl Aj^A C(kA ^41/vA (A-jxkwc Q-sAixo lmvq^ O^^ui-Ci-. va.tvdjL^ *AO* Ai.j^Ai 2).AA-fv<3-p tiAiiJAWi A) «u\Av_. -, /Ajufao

•^fs^s
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

*Time and Date:*                         9 a.m.-5 p.m., July 21, 2009 (Closed). 9 a.m.-1 p.m., July 22, 2009 (Closed).                    

*Place:*                         W Hotel, Midtown, 188 14th Street, NE., Atlanta, Georgia 30361, Telephone: (404) 892-6000.                    

*Status:*                         The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.                    

*Matters To Be Discussed:*                         The meeting will include the initial review, discussion, and evaluation of “Translating Research to Protect Health through Health Promotion, Prevention, and Preparedness, Panel D, FOA CD09-001, initial review.”                    

*For More Information Contact:*                         Christine J. Morrison, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone (404) 639-3098.                    

                        The Director, Management Analysis and Services Office, has been delegated the authority to sign                         **Federal Register**                         notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.                    

Dated: June 15, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease  Control and Prevention.

[FR Doc. E9-14659 Filed 6-22-09; 8:45 am]

BILLING CODE 4163-18-P
#### UNITED STATES of America, Plaintiff-Appellee, v. Rey David EUSEBIO-GIRON, Defendant-Appellant.

No. 05-51000

Summary Calendar.

United States Court of Appeals, Fifth Circuit.

June 22, 2006.

Joseph H. Gay, Jr., Assistant U.S. Attorney, U.S. Attorney’s Office, Western District of Texas, San Antonio, TX, for Plaintiff-Appellee.

M. Carolyn Fuentes, Federal Public Defender’s Office, Western District of Texas, San Antonio, TX, for Defendant-Appellant.

*508Before SMITH, GARZA, and PRADO, Circuit Judges.

PER CURIAM: *

Rey Eusebio-Giron pleaded guilty of illegal reentry after deportation and was sentenced to 57 months of imprisonment, three years of supervised release, and a $100 special assessment. He argues on appeal that the district court erred in determining that his prior California conviction under CalPenal Code § 261.5 for unlawful sexual intercourse qualifies under U.S.S.G. § 2L1.2 as a crime of violence because it met both the enumerated offense of statutory rape and the enumerated offense of sexual abuse of a minor. Concerning the enumerated offense of statutory rape, Eusebio-Giron contends that § 261.5 does not have an exception for sexual intercourse between contemporaries, whereas the Model Penal Code (“MPC”) definition of statutory rape excludes sexual intercourse between persons within four years of age of one another.

Eusebio-Giron bases his argument that § 261.5 does not have an exception for sexual intercourse between contemporaries on the fact that § 261.5(b) makes sexual intercourse with a minor within three years of age from the actor a misdemean- or. Because, however, Eusebio-Giron was indicted for and pleaded guilty of violating § 261.5(c), we need not consider whether the offense listed under § 261.5(b) qualifies as statutory rape under § 2L1.2. *See United States v. Izaguirre-Flores,*405 F.Bd 270, 273 n. 6 (5th Cir.2005). Section 261.5(c) contains an exception similar to that in the MPC, because it does not criminalize sexual intercourse with a minor three years or less apart in age from the actor. Accordingly, Eusebio-Giron’s argument lacks merit.

Eusebio-Giron’s constitutional challenge to 8 U.S.C. § 1326(b) is foreclosed by *Almendarez-Torres v. United States,*523 U.S. 224, 235, 118 S.Ct. 1219, 140 L.Ed.2d 350 (1998). Although he contends that *Almendarez-Torres*was incorrectly decided and that a majority of the Supreme Court would overrule *Almendarez-Torres*in light of *Apprendi v. New Jersey,*530 U.S. 466, 120 S.Ct. 2348, 147 L.Ed.2d 435 (2000), *Almendarez-Torres*remains binding. *See Rangel-Reyes v. United States,*— U.S. -, 126 S.Ct. 2873, 165 L.Ed.2d 910 (2006); *United States v. Garza-Lopez,*410 F.3d 268, 276 (5th Cir.), *cert. denied,*— U.S.-, 126 S.Ct. 298, 163 L.Ed.2d 260 (2005). Eusebio-Giron properly concedes that his argument is foreclosed in light of *AlmendarezTorres*and circuit precedent, but he raises it here to preserve it for further review.

AFFIRMED.

*

 Pursuant to 5th Cir R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.